Skip to main content
Log in

On the Variability of Dissolution Data

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To investigate dissolution data variability and its origins.

Methods. The Weibull function with four parameters, t0 (dissolution lag-time), K (the rate parameter), β (the shape parameter) and D (the fraction dissolved as t →∞), is used to describe the dissolution curve. The variance of the dissolution data is expressed in terms of these parameters and their individual variances σ2 t0, σ2 K;, σ2 β, and σ2 D. These four variances originate from variable physical properties of the dosage units and from a variable dissolution environment. Therefore, dissolution data variability depends on both, the functional form of the curve and on the variance of the physical conditions. The use of this method enables the elucidation of the sources of dissolution data variability.

Results. In the case of a sigmoidal dissolution curve (β > 1), data variance is zero as dissolution begins (following dissolution lag-time). This initial variance diverges when the dissolution curve is non-sigmoidal (with β < 1) but assumes a finite value, proportional to the dissolution lag-time variance (σ2 t0) when the data fits a regular first order rate curve (β = 1). Following a long dissolution time, data variance attains a constant value equal to the dissolution extent variance, σ2 D. When the dissolution curve is sigmoidal and the variability related to the dissolution extent is sufficiently small (σD/D << 1), a maximum in the variance is expected at some intermediate time point (corresponding to the curve inflection point, when the main source of variability is dissolution lag-time t0, or around t = 1/K + t0, when the main sources of variability are the rate parameter K or the shape parameter β). When the curve is sigmoidal (β > 1) and the main source of variability relates to the dissolution extent, the overall variance grows with time all the way to the plateau of the dissolution curve. With a non-sigmoidal dissolution curve (β ≤ 1), data variability decreases with time soon after dissolution begins. In that case, if the main source of variability is the dissolution lag-time (t0), the variance decreases all the way to the plateau of the dissolution curve. If the dissolution extent, D, is the main source of variability, a minimum in the variance is expected at some intermediate time point. The dissolution relative variance, on the other hand, diverges as dissolution begins and decreases with time at least until 63% of the drug is released, irrespective to the Weibull parameter values. Later, it may decrease or increase, attaining a fixed value (σ2 D/D2) at the plateau of the dissolution curve.

Conclusions. The particular time dependence of dissolution data variance is well defined in terms of the Weibull shape parameters and their individual variances. Dissolution data variability may decrease or increase with time along the curve. It may attain a maximum or a minimum value at some intermediate time point. It may converge or diverge as dissolution begins. When the dissolution data is well fitted to the Weibull function, the sources of data variability (in terms of the Weibull parameters) may be elucidated. The variability of dissolution data originates from physical sources but is also dependent on the functional form of the curve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. C. K. Carrico. Pharm. Res. 13(1):6-9 (1996).

    PubMed  Google Scholar 

  2. H. M. Abdou. Dissolution bioavailability and bioequivalence, Mack, Easton, PA, 1989, p. 116.

    Google Scholar 

  3. A. H. Beckett, T. T. Quach, and G. S. Kurs. Diss. Tech. 3(2):7-18 (1996).

    Google Scholar 

  4. F. Garner and J. Hoffman. AIChE J. 7:148-152 (1961).

    Google Scholar 

  5. J. G. Wagner. Biopharmaceutics and relevant pharmacokinetics, Drug Intelligence Publications, Hamilton, IL, 1971, p. 110.

    Google Scholar 

  6. F. Langenbucher. Pharm. Ind. 38(5):472-477 (1976).

    Google Scholar 

  7. J. Topping. Errors of observation and their treatment, Chapman and Hall, London, 1974.

    Google Scholar 

  8. W. Kaplan. Advanced calculus (2nd Ed.), Addison-Wesley, 1973, pp. 399-400.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elkoshi, Z. On the Variability of Dissolution Data. Pharm Res 14, 1355–1362 (1997). https://doi.org/10.1023/A:1012108402682

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012108402682

Navigation